South Atlantic Gold Inc. (JLRRF)
| Market Cap | 1.59M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -195.30K |
| Shares Out | n/a |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,000 |
| Average Volume | 53,544 |
| Open | 0.0011 |
| Previous Close | 0.0299 |
| Day's Range | 0.0011 - 0.0011 |
| 52-Week Range | 0.0011 - 0.0299 |
| Beta | 0.77 |
| RSI | 43.02 |
| Earnings Date | Jul 28, 2025 |
About Ligand Pharmaceuticals
South Atlantic Gold Inc. engages in the acquisition, exploration, and development of mineral properties in Brazil and Canada. It primarily explores for gold and copper deposits. The company holds 100% interest in the Big Kidd property located in British Columbia, Canada, and the Pedra Branca project located in Ceara State, North-eastern Brazil. The company was formerly known as Jiulian Resources Inc. and changed its name to South Atlantic Gold Inc. in November 2020. South Atlantic Gold Inc. was incorporated in 2006 and is headquartered in Kelow... [Read more]
Financial Performance
Financial StatementsNews
South Atlantic Gold Announces Termination of Amalgamation Agreement
Vancouver, B.C. – TheNewswire - June 27, 2025 – South Atlantic Gold Inc. (“ South Atlantic ” or the “ Company ”) (TSX-V: SAO) , announces that shareholders did not approve its previously announced am...